Images List Premium Download Classic

Gastrointestinal Tract

Gastrointestinal Tract-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Gastroretentive gel formulations
Jagotec Ag
November 09, 2017 - N°20170319698

The present invention provides a gastric retentive gel composition comprising: (a) a hydrophobic or amphiphilic liquid gelled with an organogelator; (b) an active agent; and (c) a hard wax or wax-like additive, for controlled delivery of the active agent to or through the upper gastrointestinal tract, in particular to or through the stomach. The gel composition forms a stable, floating ...
Soluble, stable, anti-inflammatory, proliferative, protective and mucoadhesive pharmaceutical compositions; use thereof for treating mucositis conditions ...
Universidade Federal De Goias
November 09, 2017 - N°20170319642

The present invention relates to pharmaceutical compositions with mucoadhesive and sustained release characteristics containing the association of the extract or fractions of curcuma longa l. With curcuminoid content greater than 5% and bidens pilosa (bd) extract, which has an important proliferative and anti-inflammatory effect, for the treatment of inflammatory diseases of the oral cavity (stomatitis) and of the gastrointestinal tract, as, ...
Serum-based mirna microarray and its use in diagnosis and treatment of barrett's esophagus (be) and ...
Universidade Federal De Goias
November 02, 2017 - N°20170314080

Robust and reliable molecular diagnostic screening tools for early detection of esophageal and gastrointestinal tract cancers and pre-cancerous lesions, such as barrett's esophagus, and esophageal adenocarcinoma are provided. Included in the invention is an array of mirna probes specific for identifying, diagnosing and prognosticating esophageal and gastrointestinal tract cancers and pre-cancerous lesions in subjects from blood or serum samples. A ...
Gastrointestinal Tract Patent Pack
Download + patent application PDFs
Gastrointestinal Tract Patent Applications
Download + Gastrointestinal Tract-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Gastrointestinal Tract-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Antibacterial and protective formulations and methods for making and using them
Universidade Federal De Goias
November 02, 2017 - N°20170312322

Provided are compositions and methods for treating, ameliorating and preventing various infections, disorders and conditions in mammals, including genetically-predisposed and chronic disorders, where a microbial or bacterial flora is at least one causative or symptom-producing factor, where exemplary compositions are products of manufacture, a food, a drink, a nutraceutical, a dietary supplement, a formulation, a pharmaceutical or a pharmaceutical preparation ...
New indication of azelnidipine pharmaceutical composition for treating cancer
Universidade Federal De Goias
November 02, 2017 - N°20170312260

A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of azelnidipine or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, and skin cancer.
New indication of antibiotic drugs for preparation of cancer inhibition pharmaceutical composition
Launx Biomedical Co., Ltd.
October 26, 2017 - N°20170304387

A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of an antibiotic drug or a pharmaceutical acceptable salt thereof. The antibiotic drug is selected from the group consisting of an aminoglycoside antibiotic drug, an anti-fungal antibiotic drug, a cephalosporin antibiotic drug, a β-propionamide antibiotic drug, ...
Gastrointestinal Tract Patent Pack
Download + patent application PDFs
Gastrointestinal Tract Patent Applications
Download + Gastrointestinal Tract-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Gastrointestinal Tract-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
New indication of cinacalcet hcl pharmaceutical composition for treating cancer
Launx Biomedical Co., Ltd.
October 26, 2017 - N°20170304228

A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of cinacalcet hcl or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, skin cancer, and blood cancer.
New indication of monobenzone pharmaceutical composition for treating cancer
Launx Biomedical Co., Ltd.
October 26, 2017 - N°20170304218

A method for treating a cancer includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising monobenzone or a pharmaceutical acceptable salt thereof. The cancer is selected from pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, and skin cancer. The pleural-related cancer is lung cancer. The abdominal-related cancer is selected from ...
Controlled release and taste masking oral pharmaceutical composition
Cosmo Technologies Limited
October 26, 2017 - N°20170304209

Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i. E. A structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices. The use of a plurality of systems for the control of the dissolution of the active ingredient modulates the dissolution rate of ...
Ph dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and ...
Plx Opco Inc.
October 26, 2017 - N°20170304190

Novel drug carriers capable of targeted and/or ph dependent release of biologically active agents into selected ph environments including the gastrointestinal (gi), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (ffa) are able to deliver biologically active agents to various ph environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious ...
Origami robots, systems, and methods of treatment
Children's Medical Center Corporation
October 26, 2017 - N°20170303965

Origami robots, and associated systems, methods of treatment, and methods of manufacture are provided. A system includes an origami robot encapsulated for ingestion by a patient, such as in a biocompatible material that is dissolvable or meltable within the gastrointestinal tract. A method of treatment includes delivering an origami robot in a folded position into a gastrointestinal tract of a ...
Method for treatment of disorders of the gastrointestinal system
Children's Medical Center Corporation
October 19, 2017 - N°20170296596

There are provided novel synthetic stool preparations comprising bacteria isolated from a fecal sample from a healthy donor. The synthetic stool preparations are used for treating disorders of the gastrointestinal tract, including dysbiosis, clostridium difficile infection and recurrent clostridium difficile infection, prevention of recurrence of clostridium difficile infection, treatment of crohn's disease, ulcerative colitis, irritable bowel syndrome, inflammatory bowel disease, ...
Method for diagnosing, preventing, and treating neurological diseases
Children's Medical Center Corporation
October 19, 2017 - N°20170296518

The invention provides for methods of treating autism associated with desulfovibrio overgrowth in the gastrointestinal tract of a patient, said method comprising administering to the patient suffering from said autism a treatment course of aztreonam in an amount effective to treat autism in the patient, thereby treating autism.
Gastrointestinal Tract Patent Pack
Download + patent application PDFs
Gastrointestinal Tract Patent Applications
Download + Gastrointestinal Tract-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Gastrointestinal Tract-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Electromechanical pill device with localization capabilities
Children's Medical Center Corporation
October 19, 2017 - N°20170296092

Various embodiments are described herein for a device, system, and method for identifying a location of an ingestible device within a gastrointestinal tract of a body. In some embodiments, the ingestible device includes a sensing unit with an axial optical sensing sub-unit located proximal to at least one end of the device, and a radial optical sensing sub-unit located proximal ...
Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders
New York University
October 12, 2017 - N°20170290889

The present invention relates to the use of type 2 cytokines and mucins for increasing the amount or activity of bacterial species of the clostridia class in the gastrointestinal tract, for treating dysbiosis in the gastrointestinal tract, for treating gastrointestinal and inflammatory disorders, and for promoting wound healing in the gastrointestinal tract.
Oral pharmaceutical dosage forms of budesonide
Sun Pharmaceutical Industries Ltd.
October 05, 2017 - N°20170281556

The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of crohn's disease.
Conformationally-stabilized intraluminal device for medical applications
Sun Pharmaceutical Industries Ltd.
October 05, 2017 - N°20170281383

The invention relates to devices that are stabilized at an intraluminal residence site in the gastrointestinal tract by their conformation, including dimensions of length and curvature. The device as a whole corresponds to the conformation of the residence site; more particularly, the curved or angled portions correspond to the curved or angled portions of the residence site and do not ...
Wound fluid elevated protease enzyme inhibition through camelid blood products
Sun Pharmaceutical Industries Ltd.
September 28, 2017 - N°20170274013

Camelid blood products their peptide isolates and synthetic sequences for wound fluid elevated protease enzyme inhibition. The present invention provides evidence that metalloprotease and other protease enzyme (e. G. Elastase) peptide inhibitors are present in camelid serum/plasma can be used alone or combined with other agents to enhance healing in the treatment of chronic wounds and burns by inhibiting ...
Gastrointestinal capsule and treatment method
Vibrant Ltd.
September 28, 2017 - N°20170273863

A gastrointestinal capsule (gic) including a capsule housing having a longitudinal axis; a thrusting mechanism, disposed within the housing; and a battery adapted to power the and a battery adapted to power the thrusting mechanism; the thrusting mechanism having an active mode, and a passive mode with respect to the active mode, the thrusting mechanism adapted to exert a radial ...
Minimally invasive access for renal nerve ablation
Boston Scientific Scimed, Inc.
September 28, 2017 - N°20170273741

An elongated flexible medical device is inserted into a patient's body via a natural orifice, and advanced through the natural orifice to a location proximate innervated tissue that influences renal sympathetic nerve activity. The medical device can be advanced into a body organ and to a location within the organ proximate the innervated tissue. The organ may comprise an organ ...
Omniphobic materials for bio-applications
The Brigham And Women's Hospital, Inc.
September 21, 2017 - N°20170266931

Compositions and articles comprising omniphobic materials for bio-related and other applications are generally provided. In some embodiments, the compositions and articles described herein may be introduced internally of a subject (e. G., in the esophagus, in the gastrointestinal tract, in the rectum). In some aspects, the compositions and articles comprise a releasable therapeutic agent in some embodiments, the compositions and ...
Loading